Prognostic significance of preoperative blood transfusion in stomach cancer

Journal of Gastric Cancer

Volumn 10, Issue 4, 2010, Pages 196-205

  Kim, Seok Hwan ^a   Lee, Sang Il ^a   Noh, Seung Moo ^a  

^a Chungnam National University   (South Korea)

Author keywords

Blood transfusion; Prognosis; Stomach neoplasm

Indexed keywords

EID: 84867536204     PISSN: 2093582X     EISSN: 20935641     Source Type: Journal    
DOI: 10.5230/jgc.2010.10.4.196     Document Type: Review

References (32)

1. Ministry of Health in Japan. About the use of blood products. 3rd ed. 2007.
2. Hyung WJ, Noh SH, Shin DW, Huh J, Huh BJ, Choi SH, et al. Adverse eflects of perioperative transfusion on patients with stage III and IV gastric cancer. Ann Surg Oncol 2002;9:5-12.
3. Amato A, Pescatori M. Perioperative blood transfusions for the recurrence of colorectal cancer. Cochrane Database Syst Rev 2006;(1):CD005033.
4. Nilsson KR, Berenholtz SM, Dorman T, Garrett E, Lipsett P, Kaufman HS, et al. Preoperative predictors of blood transfusion in colorectal cancer surgery. J Gastrointest Surg 2002;6:753-762.
5. Centers for Disease Control of Health and Welfare in Korea, Institute of Transfusion in Korea. Guidelines for transfusion. 2009.
6. Murphy MF, Wallington TB, Kelsey P, Boulton F, Bruce M, Cohen H, et al; British Committee for Standards in Haematology, Blood Transfusion Task Force. Guidelines for the clinical use of red cell transfusions. Br J Haematol 2001;113:24-31.
7. British Committee for Standards in Haematology, Stainsby D, MacLennan S, Thomas D, Isaac J, Hamilton PJ. Guidelines on the management of massive blood loss. Br J Haematol 2006;135:634-641.
8. Wilkerson DK, Rosen AL, Sehgal LR, Gould SA, Sehgal HL, Moss GS. Limits of cardiac compensation in anemic baboons. Surgery 1988;103:665-670.
9. Kaneda M, Horimi T, Ninomiya M, Nagae S, Mukai K, Takeda I, et al. Adverse aflect of blood transfusions on survival of patients with gastric cancer. Transfusion 1987;27:375-377.
10. Kampschoer GH, Maruyama K, Sasako M, Kinoshita T, van de Velde CJ. The eflects of blood transfusion on the prognosis of patients with gastric cancer. World J Surg 1989;13:637-643.
11. Moriguchi S, Maehara Y, Akazawa K, Sugimachi K, Nose Y. Lack of relationship between perioperative blood transfusion and survival time aft er curative resection for gastric cancer. Cancer 1990;66:2331-2335.
12. Fong Y, Karpeh M, Mayer K, Brennan MF. Association of perioperative transfusions with poor outcome in resection of gastric adenocarcinoma. Am J Surg 1994;167:256-260.
13. Singh SK, Marquet RL, de Bruin RW, Hop WC, Westbroek DL, Jeekel J. Consequences of blood loss on growth of artifi-cial metastases. Br J Surg 1988;75:377-379.
14. Benoist S, Panis Y, Pannegeon V, Alves A, Valleur P. Predictive factors for perioperative blood transfusions in rectal resection for cancer: A multivariate analysis of a group of 212 patients. Surgery 2001;129:433-439.
15. Vamvakas EC, Carven JH. Allogeneic blood transfusion, hospital charges, and length of hospitalization: a study of 487 consecutive patients undergoing colorectal cancer resection. Arch Pathol Lab Med 1998;122:145-151.
16. Matsumata T, Itasaka H, Shirabe K, Shimada M, Yanaga K, Sugimachi K. Strategies for reducing blood transfusions in hepatic resection. HPB Surg 1994;8:1-6.
17. Opelz G, Terasaki PI. Poor kidney-transplant survival in recipients with frozen-blood transfusions or no transfusions. Lancet 1974;2:696-698.
18. Taylor RW, Manganaro L, O'Brien J, Trottier SJ, Parkar N, Veremakis C. Impact of allogenic packed red blood cell transfusion on nosocomial infection rates in the critically ill patient. Crit Care Med 2002;30:2249-2254.
19. Nowak MM, Ponsky JL. Blood transfusion and disease-free survival in carcinoma of the breast. J Surg Oncol 1984;27:124-130.
20. Hyman NH, Foster RS Jr, DeMeules JE, Costanza MC. Blood transfusions and survival after lung cancer resection. Am J Surg 1985;149:502-507.
21. Manyonda IT, Shaw DE, Foulkes A, Osborn DE. Renal cell carcinoma: blood transfusion and survival. Br Med J (Clin Res Ed) 1986;293:537-538.
22. Johnson JT, Taylor FH, Thearle PB. Blood transfusion and outcome in stage III head and neck carcinoma. Arch Otolaryngol Head Neck Surg 1987;113:307-310.
23. Grzelak I, Zaleska M, Olszewski WL. Blood transfusions downregulate hematopoiesis and subsequently downregulate the immune response. Transfusion 1998;38:1104-1114.
24. Carson JL, Chen AY. In search of the transfusion trigger. Clin Orthop Relat Res 1998;357:30-35
25. Chen AY, Carson JL. Perioperative management of anaemia. Br J Anaesth 1998;81(Suppl 1):20-24.
26. Carson JL, Duff A, Poses RM, Berlin JA, Spence RK, Trout R, et al. Eflect of anaemia and cardiovascular disease on surgical mortality and morbidity. Lancet 1996;348:1055-1060.
27. Practice Guidelines for blood component therapy: a report by the American society of anesthesiologists task force on blood component therapy. Anesthesiology 1996;84:732-747.
28. Consensus Conference. Perioperative red blood cell transfusion. JAMA 1988;260:2700-2703.
29. van de Watering LM, Hermans J, Houbiers JG, van den Broek PJ, Bouter H, Boer F, et al. Beneficial effects of leukocyte depletion of transfused blood on postoperative complications in patients undergoing cardiac surgery: a randomized clinical trial. Circulation 1998;97:562-568.
30. Naidech AM, Drescher J, Ault ML, Shaibani A, Batjer HH, Alberts MJ. Higher hemoglobin is associated with less cerebral infarction, poor outcome, and death after subarachnoid hemorrhage. Neurosurgery 2006;59:775-779.
31. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987;40:373-383.
32. Lubke T, Monig SP, Schneider PM, Holscher AH, Bollschweiler E. Does Charlson-comorbidity index correlate with shortterm outcome in patients with gastric cancer? Zentralbl Chir 2003;128:970-976.